Anna Kálosi

2PUBLICATIONS
11CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 19, 2021
Targeting acute myeloid leukemia cells by CD33 receptor-specific MoS2-based nanoconjugates.

Pavol Štefík, Adriana Annušová, Boris Lakatoš

|Feb 18, 2020
A bioconjugated MoS2 based nanoplatform with increased binding efficiency to cancer cells.

Anna Kálosi, Martina Labudová, Adriana Annušová

Pageof 1